Healthcare -
Biotechnology - NASDAQ - US
$ 57.76
8.14 %
$ 4.33 B
Market Cap
-16.6
P/E
Price Target
Average
30.59%
Revenue Forecast
Estimate
91.97%
EBIT
Estimate
0.85%
Net Income
Estimate
49.91%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
SpringWorks Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for SWTX of $75.4 , with forecasts ranging from
a
low of
$50 to a high of $94 .
SWTX Lowest Price Target
Wall Street Target
50 USD
-13.43%
SWTX Average Price Target
Wall Street Target
75.4 USD
30.59%
SWTX Highest Price Target
Wall Street Target
94 USD
62.74%
REVENUE FORECAST
Revenue Forecast Chart SWTX
EBIT FORECAST
EBIT Forecast Chart SWTX
NET INCOME FORECAST
Net Income Chart SWTX